At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Managing Cancer and Living Meaningfully (CALM) Therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Managing Cancer and Living Meaningfully (CALM) in Primary Brain Tumor Patients
In Brief
A clinical study evaluating Managing Cancer and Living Meaningfully (CALM) Therapy for Mood and Cancer Brain. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to pilot test an empirically supported psychotherapeutic intervention, Managing Cancer and Living Meaningfully (CALM). Researchers hope to better understand the potential benefits of this intervention on brain tumor patients' mood and quality of life. This may lead to improvements in doctor's understanding of how to enhance brain tumor patient's wellbeing and overall functioning.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMood, Cancer Brain
CountriesUnited States
CollaboratorsAmerican Cancer Society, Inc.
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartDec 2020
Primary CompletionSep 2021
Study CompletionFeb 2022
TodayJul 2026
First PostedNov 27, 2020
Enrollment StartDec 3, 2020
Primary CompletionSep 14, 2021
Study CompletionFeb 14, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.6 years ago
Interventions
Managing Cancer and Living Meaningfully (CALM) Therapybehavioral
6 sessions of individualized CALM therapy